Related articles

• News Brief

  SEC levies no fine against Kiromic BioPharma after material omissions self-disclosure

  Dec 3, 2024 9:48 AM By Aaron Nicodemus

  Kiromic BioPharma will pay no fine to the Securities and Exchange Commission after self-reporting that it failed to disclose material information about two cancer drugs to investors.

• Premium

  Could your firm potentially be the subject of a DOJ whistleblower action? Time to get ready

  Nov 27, 2024 10:22 AM By Aaron Nicodemus

  Now that the U.S. Department of Justice launched a new pilot whistleblower program, many questions remain. What types of companies might find themselves to be the subject of a criminal investigation stemming from a whistleblower tip? And what should they do to prepare for a whistleblower tip?

• Webcast

  The Department of Justice received more than 200 whistleblower tips since it launched its long-awaited Corporate Whistleblower Awards (CWA) Pilot Program on Aug. 1, according to the program’s Acting Director Patrick Gushue in a Compliance Week exclusive.

Read Full Story: https://news.google.com/rss/articles/CBMi7AFBVV95cUxNSktDUkM0RTRSV2ZSQ2dBQ0la...